Literature DB >> 17375919

Synthesis of nitric oxide-releasing silica nanoparticles.

Jae Ho Shin1, Sara K Metzger, Mark H Schoenfisch.   

Abstract

The synthesis and characterization of a new nitric oxide (NO)-releasing scaffold prepared from amine-functionalized silica nanoparticles are reported. Inorganic-organic hybrid silica was prepared via cocondensation of tetraethoxy- or tetramethoxysilane (TEOS or TMOS) and aminoalkoxysilane with appropriate amounts of ethanol (or methanol), water, and ammonia. The amine functional groups in the silica were converted to N-diazeniumdiolate NO donors via exposure to high pressures of NO (5 atm) under basic conditions. Control over both the structure and concentration of the silane precursors (i.e., tetraalkoxy- and aminoalkoxysilanes) and specific synthetic conditions allowed for the preparation of NO donor silica particles of widely varying sizes (d = 20-500 nm), NO payloads (50-1780 nmol.mg-1), maximum amounts of NO released (10-5500 ppb.mg-1), half-lives (0.1-12 h), and NO release durations (up to 30 h). The silica nanoparticles were characterized by solid-state 29Si nuclear magnetic resonance (NMR), atomic force microscopy (AFM), elemental analysis, and gas adsorption-desorption isotherms. The advantages of silica-derived NO storage/delivery systems over previously reported macromolecular NO donors include the ability to (1) store large quantities of NO, (2) modulate NO release kinetics, and (3) readily tune particle size based on the composition of the particle. In addition, a one-pot strategy for preparing the NO donor silica allows for straightforward, high-throughput synthesis and purification.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17375919     DOI: 10.1021/ja0674338

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  42 in total

1.  Glucose sensor membranes for mitigating the foreign body response.

Authors:  Ahyeon Koh; Scott P Nichols; Mark H Schoenfisch
Journal:  J Diabetes Sci Technol       Date:  2011-09-01

Review 2.  Local delivery of nitric oxide: targeted delivery of therapeutics to bone and connective tissues.

Authors:  Scott P Nichols; Wesley L Storm; Ahyeon Koh; Mark H Schoenfisch
Journal:  Adv Drug Deliv Rev       Date:  2012-03-10       Impact factor: 15.470

3.  The effect of nitric oxide surface flux on the foreign body response to subcutaneous implants.

Authors:  Scott P Nichols; Ahyeon Koh; Nga L Brown; Michael B Rose; Bin Sun; Danielle L Slomberg; Daniel A Riccio; Bruce Klitzman; Mark H Schoenfisch
Journal:  Biomaterials       Date:  2012-06-27       Impact factor: 12.479

4.  Nonporous Silica Nanoparticles for Nanomedicine Application.

Authors:  Li Tang; Jianjun Cheng
Journal:  Nano Today       Date:  2013-06       Impact factor: 20.722

5.  Stöber Synthesis of Nitric Oxide-Releasing S-Nitrosothiol-Modified Silica Particles.

Authors:  Daniel A Riccio; Julia L Nugent; Mark H Schoenfisch
Journal:  Chem Mater       Date:  2011-04-12       Impact factor: 9.811

Review 6.  Biomineralized hybrid nanoparticles for imaging and therapy of cancers.

Authors:  Kyung Hyun Min; Hong Jae Lee; Sang Cheon Lee; Kyeongsoon Park
Journal:  Quant Imaging Med Surg       Date:  2018-08

Review 7.  Nitric oxide release: part I. Macromolecular scaffolds.

Authors:  Daniel A Riccio; Mark H Schoenfisch
Journal:  Chem Soc Rev       Date:  2012-02-24       Impact factor: 54.564

Review 8.  Biocompatible materials for continuous glucose monitoring devices.

Authors:  Scott P Nichols; Ahyeon Koh; Wesley L Storm; Jae Ho Shin; Mark H Schoenfisch
Journal:  Chem Rev       Date:  2013-02-07       Impact factor: 60.622

9.  Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles.

Authors:  Evan M Hetrick; Jae Ho Shin; Heather S Paul; Mark H Schoenfisch
Journal:  Biomaterials       Date:  2009-02-23       Impact factor: 12.479

Review 10.  Nitric Oxide-Releasing Macromolecular Scaffolds for Antibacterial Applications.

Authors:  Lei Yang; Evan S Feura; Mona Jasmine R Ahonen; Mark H Schoenfisch
Journal:  Adv Healthc Mater       Date:  2018-05-14       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.